Clinical trials
Type 2 Diabetes (T2DM) clinical trials
Below are recruiting type 2 diabetes (t2dm) clinical trials, each written for real people, not researchers. We’re tracking 229 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07728669Recruiting
Digital diet app for people on GLP-1 therapy
This study tests a smartphone app that gives dietary advice to people who are overweight or obese and also take a GLP-1 medication (like semaglutide) for weight or diabetes. The app will help you follow a healthy eating plan while using the medication.
AlmatyAges 21–65 - NCT07719894RecruitingPhase 4
Preventing heart problems in type 2 diabetes with cilostazol and aspirin
This trial tests whether taking cilostazol and aspirin together can help prevent heart attacks, strokes, and other cardiovascular events in people with type 2 diabetes who have early signs of artery disease or metabolic syndrome. It aims to see if this combination is more effective than aspirin alone.
Seongnam-si, Gyeonggi-doAges 19 years+ - NCT07703345Recruiting
Saliva markers in people with diabetes and gum disease
This study checks whether certain substances in saliva can help detect gum disease in people with type 2 diabetes. It compares the levels of these substances in people with diabetes and gum disease, people with gum disease only, people with diabetes only, and healthy volunteers.
Konya, KonyaAges 18–80 - NCT07690163Recruiting
Diabetes blood sugar check in newly diagnosed patients
This trial is checking how well blood sugar is controlled in adults recently diagnosed with type 2 diabetes (within the last 3 months). It aims to see if current treatments or lifestyle changes are working and may help guide future care.
KyivAges 18 years+ - NCT07693036RecruitingPhase 1/Phase 2
Exosomes from stem cells for type 2 diabetes
This trial tests if a type of stem cell product (exosomes) can safely and effectively help people with type 2 diabetes. Researchers will give infusions to see if it improves blood sugar control and pancreatic function.
BeijingAges 18–65 - NCT07674628Recruiting
Coping skills program for Hispanic/Latinx military patients with diabetes
This study tests a program to help Hispanic/Latinx military patients with type 2 diabetes learn healthier ways to cope with stress and manage their diabetes. It may help you improve your blood sugar control and daily self-care.
San Antonio, TexasAges 18–70 - NCT07678866Recruiting
Electric pulse study for type 2 diabetes with poor drug control
This trial tests a new procedure called pulse electric field ablation to see if it can help people with type 2 diabetes whose blood sugar is not well controlled by oral medications. The procedure uses a small device passed through the mouth to the upper intestine.
ShanghaiAges 18–70 - NCT07677995Enrolling by invitation
Fatty acids and type 2 diabetes study
This study looks at how free fatty acids affect people with type 2 diabetes or pre-diabetes. You may be able to join if you are overweight, have high blood sugar, and are not on certain diabetes medications.
Coleraine, County LondonderryAges 18 years+ - NCT07676773Recruiting
Remote exercise study for type 2 diabetes
This trial tests if a remote exercise program can help control blood sugar and improve fitness in people with type 2 diabetes. It is for those who are newly diagnosed or have had diabetes for up to 5 years and are not taking diabetes medication.
Chengdu, SichuanAges 18–69 - NCT07670416RecruitingPhase 3
A study of enicepatide for people with obesity or overweight
This trial tests if enicepatide can help people with obesity or overweight lose weight, including those with or without type 2 diabetes. It aims to see if the drug is safe and effective.
Zhengzhou, HenanAges 18 years+ - NCT07664553RecruitingPhase 3
Testing a new diabetes tablet for people on insulin
This trial tests a new once-daily tablet (elecoglipron) against a placebo to see if it can help improve blood sugar control in adults with type 2 diabetes who are already on insulin. It may offer an additional treatment option to help manage your diabetes.
Little Rock, ArkansasAges 18 years+ - NCT07665567Enrolling by invitation
Helping reverse type 2 diabetes with lifestyle changes and monitoring
This study tests if a coaching program focused on diet, activity, and blood sugar tracking can help people with early type 2 diabetes put their diabetes into remission. You'll receive guidance and tools to manage your health and potentially reduce or stop diabetes medications.
Hamilton, OntarioAges 30–80 - NCT07662109RecruitingPhase 3
Testing a new combo pill for type 2 diabetes
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
Huntsville, AlabamaAges 18 years+ - NCT07659574RecruitingPhase 3
Study of UBT251 injection for type 2 diabetes not controlled by diet and exercise
This trial tests a new injected drug (UBT251) for people with type 2 diabetes who haven't been able to control their blood sugar with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels safely.
Changsha, HunanAges 18–75 - NCT07662213RecruitingPhase 3
Elecoglipron vs semaglutide for type 2 diabetes
This study tests an experimental diabetes pill (elecoglipron) to see if it works as well as a current medicine, semaglutide, for people with type 2 diabetes who also have heart risk factors. It aims to help better control blood sugar and weight.
Birmingham, AlabamaAges 18 years+ - NCT07662044RecruitingPhase 3
Studying elecoglipron for type 2 diabetes
This trial tests a new medicine called elecoglipron, taken alone or with another diabetes drug (dapagliflozin), to see if it helps control blood sugar better than a placebo. It may be an option if your current treatment isn't working well enough.
Birmingham, AlabamaAges 18 years+ - NCT07656805Recruiting
Anti-inflammatory diet for type 2 diabetes
This trial tests whether an anti-inflammatory diet can help people with type 2 diabetes. You will follow a special meal plan and have regular checkups to see how it affects your blood sugar and overall health.
Hefei, AnhuiAges 18 years+ - NCT07660445Recruiting
Endoscopic stomach reshaping and duodenal procedure for obese type 2 diabetes
This trial tests a procedure that reshapes the stomach and treats the upper intestine to help control blood sugar and weight in people with obesity and type 2 diabetes. It may be an option if you have a moderate to high need for metabolic surgery.
ShatinAges 18–70 - NCT07659925Recruiting
Strength training with changing levels for type 2 diabetes
This study tests whether a special strength-training program, designed with changing exercise levels (periodization), can help people with type 2 diabetes improve their blood sugar control and overall fitness. It is a good option for adults with diabetes who are not currently in a regular exercise routine.
Ankara, AnkaraAges 18–65 - NCT07653477RecruitingPhase 3
New diabetes drug for type 2 diabetes not well controlled with metformin
This trial tests an investigational drug called UBT251 for people with type 2 diabetes whose blood sugar is not well controlled despite taking metformin, either alone or with another diabetes medicine. The goal is to see if it can lower blood sugar levels more than a placebo.
ShanghaiAges 18–75 - NCT07650318Recruiting
Virtual reality brain training for diabetes patients with memory issues
This trial tests whether virtual reality brain training can help protect thinking and memory in people with type 2 diabetes who have mild memory problems. If you have type 2 diabetes and notice some mental decline, this study may help you find ways to keep your mind sharp.
Nanjing, JiangsuAges 45–80 - NCT07649967Recruiting
Mixed Reality Balance and Movement Tests for Type 2 Diabetes
This study tests whether new virtual-reality-based balance and movement tests work well for people with type 2 diabetes. Researchers want to see if these tests can safely and accurately measure how well people can move and balance.
Konya, SelcukluAges 18–65 - NCT06214520Recruiting
App and AI support for managing type 2 diabetes
This trial tests whether a smartphone app and smartwatch can help you better manage your type 2 diabetes. You'll get motivational support and an AI coach to guide your care.
SingaporeAges 21–100 - NCT07630233RecruitingPhase 1
Safety and effects of UBT38006 injection in healthy men
This early-stage study tests a new injectable medication (UBT38006) in healthy adult men to understand how safe it is and how the body processes it. Researchers want to make sure the injection doesn't cause serious side effects and works as expected.
Hefei, AnhuiAges 18–45
Hear when a new Type 2 Diabetes (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes (t2dm)?
- Yes. Clin2 currently lists 229 recruiting type 2 diabetes (t2dm) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes (t2dm) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes (t2dm) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.